1. Home
  2. FEMY vs MLEC Comparison

FEMY vs MLEC Comparison

Compare FEMY & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • MLEC
  • Stock Information
  • Founded
  • FEMY 2004
  • MLEC 2008
  • Country
  • FEMY United States
  • MLEC Cayman Islands
  • Employees
  • FEMY N/A
  • MLEC N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • MLEC Blank Checks
  • Sector
  • FEMY Health Care
  • MLEC Finance
  • Exchange
  • FEMY Nasdaq
  • MLEC Nasdaq
  • Market Cap
  • FEMY 12.5M
  • MLEC 12.9M
  • IPO Year
  • FEMY 2021
  • MLEC N/A
  • Fundamental
  • Price
  • FEMY $0.36
  • MLEC $1.20
  • Analyst Decision
  • FEMY Strong Buy
  • MLEC
  • Analyst Count
  • FEMY 3
  • MLEC 0
  • Target Price
  • FEMY $7.33
  • MLEC N/A
  • AVG Volume (30 Days)
  • FEMY 2.9M
  • MLEC 241.1K
  • Earning Date
  • FEMY 11-11-2025
  • MLEC 10-01-2025
  • Dividend Yield
  • FEMY N/A
  • MLEC N/A
  • EPS Growth
  • FEMY N/A
  • MLEC N/A
  • EPS
  • FEMY N/A
  • MLEC N/A
  • Revenue
  • FEMY $1,887,016.00
  • MLEC N/A
  • Revenue This Year
  • FEMY $103.55
  • MLEC $20.42
  • Revenue Next Year
  • FEMY $148.13
  • MLEC $30.00
  • P/E Ratio
  • FEMY N/A
  • MLEC N/A
  • Revenue Growth
  • FEMY 98.61
  • MLEC 170.36
  • 52 Week Low
  • FEMY $0.31
  • MLEC $1.10
  • 52 Week High
  • FEMY $1.80
  • MLEC $10.47
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 28.31
  • MLEC 23.08
  • Support Level
  • FEMY $0.35
  • MLEC $1.10
  • Resistance Level
  • FEMY $0.40
  • MLEC $1.45
  • Average True Range (ATR)
  • FEMY 0.04
  • MLEC 0.12
  • MACD
  • FEMY 0.01
  • MLEC 0.10
  • Stochastic Oscillator
  • FEMY 5.20
  • MLEC 28.57

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: